ARCHIVES

Signet Cell A Rising Trend In Patients Under Age 40

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | November 25, 2011

Download PDF Visit The Full Archive

Related Articles

Counter-Point: George Sledge Responds To Berry’s Letter: Neoadjuvant Doesn’t Predict Adjuvant In Breast Cancer

July 11, 2014

Clinical Trials Approved By NCI Last Month Are Listed

April 25, 2003

DRCCA Staff Boom To 145, Still Growing, Still Looking for People

November 25, 1983

Applications Due Sept. 1 For Cancer Prevention Fellows

May 10, 1991

Cooperative Groups With Cancer Control Contracts Receive Two Year Renewals

March 25, 1983

Aphton To Test Anti-Gastrin Drug At M. D. Anderson. NAS

March 31, 2000